Skip to content

Chronic Pain and Transcranial Direct Current Stimulation in Clinical Settings

Reduce Chronic Pain With Transcranial Direct Current Stimulation in Clinical Settings

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04726423
Enrollment
30
Registered
2021-01-27
Start date
2021-01-04
Completion date
2023-12-31
Last updated
2023-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

transcranial direct current stimulation, physical exercise, physiotherapy, clinical settings

Brief summary

Physical exercises and transcranial direct current stimulation (tDCS) are both known to reduce chronic pain in structured laboratory studies. The aim of this study is to assess the efficacy of this combined treatment in clinical settings.

Detailed description

Chronic pain patients who are going to the physiotherapy clinic to receive tDCS treatment sessions are evaluated in order to assess the efficacy of tDCS in clinical settings. Physiotherapists prescribe physical exercises adapted to the patients conditions. Patients performed their physical exercises every time they received a tDCS treatment, but were also recommended to continue their physical exercises program at home after completion of physiotherapy visits. Concerning tDCS treatment, patients were encouraged to receive 1 tDCS session per day for 5 consecutive days.

Interventions

OTHERtranscranial direct current stimulation

5 daily sessions of tDCS (2mA, 20 min) were recommended to all patients. Physical exercises were also done at the physiotherapy clinic. Physical exercises program was recommended to be continued at home after the week of physiotherapy visits.

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* To have chronic pain

Exclusion criteria

* Contraindication to tDCS

Design outcomes

Primary

MeasureTime frameDescription
Change in Brief Pain InventoryBaseline, 1 week, 1 monthPhysical Function
Change in Beck Depression InventoryBaseline, 1 week, 1 monthDepression
Change in Patient global impression of change1 week, 1 monthImpression of change
Change in McGill pain QuestionnaireBaseline, 1 week, 1 monthqualitative and quantitative aspects of pain
Change in Tampa QuestionnaireBaseline, 1 week, 1 monthKinesiophobia

Secondary

MeasureTime frameDescription
Side effectThrough study completion, an average of 5 daysSide effect reported by the patients (headache, dizziness, fatigue, nausea, redness, tingling)
Number of sessions receivedThrough study completion, an average of 5 daysFeasibility; did the patients received all their tDCS sessions in 5 days (1 per day)

Countries

Canada

Contacts

Primary ContactGuillaume Leonard, PhD
guillaume.leonard2@usherbrooke.ca1 819-780-2220
Backup ContactMarie-Philippe Harvey, M.Sc
marie.philippe.harvey@usherbrooke.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026